David C. Lowance

975 total citations · 1 hit paper
6 papers, 717 citations indexed

About

David C. Lowance is a scholar working on Nephrology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, David C. Lowance has authored 6 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Nephrology, 3 papers in Public Health, Environmental and Occupational Health and 1 paper in Molecular Biology. Recurrent topics in David C. Lowance's work include Organ Donation and Transplantation (3 papers), Palliative Care and End-of-Life Issues (2 papers) and Healthcare Policy and Management (1 paper). David C. Lowance is often cited by papers focused on Organ Donation and Transplantation (3 papers), Palliative Care and End-of-Life Issues (2 papers) and Healthcare Policy and Management (1 paper). David C. Lowance collaborates with scholars based in United States. David C. Lowance's co-authors include Adam Crisp, Patrick J. Brennan, Douglas J. Norman, Christophe Legendre, Josef Kovařík, R. Méndez, Michael R. Keating, James D. Mullins, John J. McPhaul and William D. Mattern and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Kidney International.

In The Last Decade

David C. Lowance

6 papers receiving 655 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal Transplantation

1999 536 citations David C. Lowance, Christophe Legendre et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David C. Lowance United States	6	508	133	130	126	118	6	717
M.R.N. Nampoory Kuwait	16	273 0.5×	79 0.6×	164 1.3×	118 0.9×	25 0.2×	49	692
Katherina Morawski United States	11	299 0.6×	90 0.7×	107 0.8×	80 0.6×	71 0.6×	16	633
P. Kramer Netherlands	12	213 0.4×	38 0.3×	62 0.5×	151 1.2×	45 0.4×	22	490
Tomáš Reischig Czechia	18	676 1.3×	217 1.6×	190 1.5×	54 0.4×	244 2.1×	42	930
Richard Rohrer United States	11	291 0.6×	65 0.5×	80 0.6×	37 0.3×	60 0.5×	20	611
Jose M. El‐Amm United States	11	306 0.6×	76 0.6×	124 1.0×	37 0.3×	62 0.5×	13	601
First Mr United States	12	182 0.4×	105 0.8×	68 0.5×	32 0.3×	25 0.2×	46	569
Francis H. Wright United States	16	240 0.5×	143 1.1×	104 0.8×	46 0.4×	99 0.8×	39	906
T. Pruett United States	15	342 0.7×	57 0.4×	62 0.5×	88 0.7×	22 0.2×	26	766
Luiz Estevam Ianhez Brazil	17	171 0.3×	40 0.3×	98 0.8×	137 1.1×	40 0.3×	54	729

Countries citing papers authored by David C. Lowance

Since Specialization

Citations

This map shows the geographic impact of David C. Lowance's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Lowance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Lowance more than expected).

Fields of papers citing papers by David C. Lowance

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Lowance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Lowance. The network helps show where David C. Lowance may publish in the future.

Co-authorship network of co-authors of David C. Lowance

This figure shows the co-authorship network connecting the top 25 collaborators of David C. Lowance. A scholar is included among the top collaborators of David C. Lowance based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C. Lowance. David C. Lowance is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Lowance, David C.. (2002). Withholding and Withdrawal of Dialysis in the Elderly. Seminars in Dialysis. 15(2). 88–90. 8 indexed citations

2.

Lowance, David C., Christophe Legendre, Josef Kovařík, et al.. (1999). Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal Transplantation. New England Journal of Medicine. 340(19). 1462–1470. 536 indexed citations breakdown →

3.

Lowance, David C.. (1993). Factors and Guidelines to be Considered in Offering Treatment to Patients With End-Stage Renal Disease: A Personal Opinion. American Journal of Kidney Diseases. 21(6). 679–683. 19 indexed citations

4.

Lowance, David C., Peter Singer, & Mark Siegler. (1988). Withdrawal from dialysis: An ethical perspective. Kidney International. 34(1). 124–135. 16 indexed citations

5.

Lowance, David C., James D. Mullins, & John J. McPhaul. (1973). Immunoglobulin A (IgA) associated glomerulonephritis. Kidney International. 3(3). 167–176. 106 indexed citations

6.

Lowance, David C., et al.. (1972). The effect of chronic hypotonic volume expansion on the renal regulation of acid-base equilibrium. Journal of Clinical Investigation. 51(11). 2928–2940. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact